Health in Somalia 1,008 indicators covering health for Somalia. IndicatorLatest Year10-yr change Rank Burden of disease who 79,453 2021 down 36.8% 3rd Total disease burden who 13.56 million 2021 down 11.8% 40th Rate of disease burden from drug use disorders who 56.28 2021 up 12.6% 164th Male female ratio suicides rates 1.72 2021 down 23.1% 180th Number of people notified with new episode of TB in a given year 17,504 2021 up 45.6% 41st Number of people diagnosed with new episode of pulmonary TB who are 4,225 2021 up 33.7% 37th Number of people diagnosed with new episode of pulmonary TB who have 4,786 2021 up 111.7% 26th Antiretroviral therapy coverage for PMTCT 43.0% 2024 up 514.3% 69th Cases started on MDR-TB treatment 419 2024 up 451.3% 35th Malaria incidence per 1,000 population at risk 53.28 per 1,000 people 2024 up 14.3% 36th Number of people diagnosed with new episode of pulmonary TB who are 8,411 2021 up 42.9% 43rd Number of people requiring interventions against neglected tropical 3.79 million 2024 down 22.5% 41st Raised fasting blood glucose (>=7.0 mmol/L) 6.8 2014 up 19.3% 144th Mean fasting blood glucose (mmol/l) 4.7 2014 down 2.6% 176th Raised fasting blood glucose (>= 7.0 mmol/L) 4.8 2014 up 17.1% 165th Reported number of people requiring interventions against NTDs 3.79 million 2024 down 22.5% 47th Child deaths from streptococcus by disease 286 2015 unchanged 16th Percentage of total deaths due to NCDs overall and percentage of 62.17 2019 down 10.6% 6th Number of new leprosy cases 1,161 2024 up 8,192.9% 15th Total official development assistance to medical research and basic 108.84 million constant US$ 2024 up 52.6% 21st Inactivated first-dose polio vaccine (IPV1) immunization coverage 70.0% 2025 — 171st Number of new hivaids infections who 500 2022 down 12.3% 90th Incidence of malaria 53.28 per 1,000 population at risk 2024 up 14.3% 39th Reported number of children receiving antiretroviral therapy 162 2025 up 44.6% 67th Concentrations of fine particulate matter 17.63 2023 up 3.1% 94th Death rate road traffic injuries 27.4 2019 down 1.1% 37th New or unknown treatment history cases: Pulmonary, bacteriologically 9,122 2023 up 39.5% 46th Cholera case fatality rate 0.74 2021 down 49.3% 28th Life satisfaction vs life expectancy 58.82 2023 up 8.9% 224th Tb patients tested positive for hiv 139 2021 down 32.5% 75th Number of children aged 6-59 months with anaemia 1,423 2019 up 7.0% 40th Prevalence of anaemia in children aged 6-59 months 51.8% 2019 down 13.7% 38th Number of deaths attributed to non-communicable diseases, by type of 8,335 2019 up 28.6% 97th Hepatitis B surface antigen (HBsAg) prevalence 4.0% 2024 down 54.0% 2nd Mean hemoglobin level of children aged 6-59 months 108 2019 up 3.8% 153rd Estimated number of MDR/RR-TB incident cases 1,200 2024 down 29.4% 31st Mortality caused by road traffic injury 27.4 per 100,000 population 2019 down 0.4% 37th Mortality caused by road traffic injury, female 15.8 per 100,000 female population 2019 down 1.9% 30th Mortality caused by road traffic injury, male 39.1 per 100,000 male population 2019 up 0.8% 38th Ipv vaccine coverage 70 2024 up 48.9% 169th Deaths in armed conflicts by country, annual growth rate -65.88 % change on previous year 2026 down 200.0% 5th Deaths in armed conflicts by region, annual growth rate -65.88 % change on previous year 2026 down 200.0% 5th Tb patients living with hiv receiving art 84 2021 up 104.9% 83rd HIV-positive TB patients on ART (antiretroviral therapy) 79.0% 2024 up 75.6% 117th Hospital beds 8.7 2019 unchanged 131st Treatment success rate for patients treated for MDR-TB 86.0% 2022 up 11.7% 31st New leprosy case detection rate per 1 000 000 population 61.08 2024 up 4,612.6% 13th Treatment success rate: HIV-positive TB cases 49 2023 down 29.0% 135th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 51.0% 2025 — 153rd International Health Regulations core capacity scores, SPAR version 20 2025 — 161st Leprosy registered prevalence rate per 1 000 000 population 44.66 2024 up 3,346.2% 19th Leprosy - Number of new leprosy cases among children 34 2024 up 1,600.0% 22nd Leprosy - Number of cases registered for treatment 849 2024 up 5,964.3% 18th New leprosy child case detection rate (less than 15 years of age) per 3.84 2024 up 1,107.2% 25th Children (0-14) living with HIV 860 2024 down 38.6% 59th Ipv1 number unvaccinated 224,489 2023 down 31.2% 22nd Children living with hiv 860 2024 down 38.6% 59th Children (ages 0-14) newly infected with HIV 100 2022 down 80.0% 51st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Number of children newly infected with hiv 100 2022 down 80.0% 51st ← Previous Page 14 of 17 Next →